Physician profile
Walter Pang
NPI 1548692130
$4,409.93
in general payments reported to CMS, 2019-2025
18 companies · $510 in 2025
The $510 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $242 · 2021: $561 · 2022: $1,232 · 2023: $686 · 2024: $702 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,897.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $763.14 | 2019-2025 | Total30, Precision7, Precision 1 |
| Johnson & Johnson Vision Care, INC. | $709.70 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $692.98 | 2022-2025 | Infuse, Vyzulta, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $304.20 | 2019-2021 | |
| Coopervision INC. | $272.26 | 2019-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Mallinckrodt Hospital Products INC. | $264.74 | 2021-2023 | Acthar |
| Glaukos Corporation | $182.66 | 2022 | |
| Eyevance Pharmaceuticals LLC | $181.01 | 2019-2023 | Tobradex St, Flarex |
| Novartis Pharmaceuticals Corporation | $172.49 | 2020-2023 | |
| Sun Pharmaceutical Industries INC. | $138.90 | 2021-2024 | Cequa |
| Oyster Point Pharma, INC. | $132.96 | 2022-2024 | Tyrvaya |
| Optos, INC. | $126.01 | 2019 | |
| Sight Sciences, INC. | $113.84 | 2022 | |
| Biotissue Holdings INC. | $94.00 | 2025 | |
| Allergan, INC. | $93.97 | 2019-2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $84.20 | 2022 | |
| Abbvie INC. | $68.97 | 2022-2024 | |
| Kala Pharmaceuticals, INC. | $13.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Pang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.